Aveanna Healthcare (NASDAQ:AVAH) Research Coverage Started at William Blair

William Blair initiated coverage on shares of Aveanna Healthcare (NASDAQ:AVAH) in a research note published on Monday, MarketBeat reports. The brokerage issued an outperform rating on the stock.

Several other brokerages have also recently weighed in on AVAH. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Aveanna Healthcare in a research note on Wednesday, October 8th. Royal Bank Of Canada increased their target price on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a report on Friday, October 24th. Raymond James Financial reaffirmed an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Truist Financial lifted their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday, November 7th. Finally, Zacks Research downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $10.69.

Aveanna Healthcare Price Performance

AVAH stock opened at $9.02 on Monday. The stock has a 50-day moving average price of $9.11 and a two-hundred day moving average price of $7.10. Aveanna Healthcare has a 1 year low of $3.67 and a 1 year high of $10.32. The stock has a market cap of $1.88 billion, a PE ratio of 25.06 and a beta of 2.04. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The company had revenue of $450.53 million for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%. Equities analysts forecast that Aveanna Healthcare will post -0.06 EPS for the current fiscal year.

Insider Activity

In other news, major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of the company’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $11,267,181.00. Following the sale, the insider directly owned 19,292,787 shares of the company’s stock, valued at approximately $173,635,083. This represents a 6.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Paul R. Vigano sold 1,500,000 shares of Aveanna Healthcare stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider owned 362,746 shares of the company’s stock, valued at $3,264,714. The trade was a 80.53% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 32,597,968 shares of company stock valued at $293,381,712. 7.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Caxton Associates LLP bought a new stake in Aveanna Healthcare in the 3rd quarter valued at $488,000. PharVision Advisers LLC increased its holdings in shares of Aveanna Healthcare by 37.6% in the third quarter. PharVision Advisers LLC now owns 20,595 shares of the company’s stock valued at $183,000 after purchasing an additional 5,630 shares during the last quarter. XTX Topco Ltd bought a new position in shares of Aveanna Healthcare in the third quarter valued at about $531,000. Voleon Capital Management LP acquired a new stake in shares of Aveanna Healthcare during the 3rd quarter worth about $2,949,000. Finally, Qube Research & Technologies Ltd boosted its holdings in shares of Aveanna Healthcare by 2.5% during the 3rd quarter. Qube Research & Technologies Ltd now owns 448,693 shares of the company’s stock worth $3,980,000 after buying an additional 10,855 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.